Orladeyo
Orladeyo is an originator product from BioCryst Schweiz GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 13'396.10 to CHF 13'396.10 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- BioCryst Schweiz GmbH
- ATC code
- B06AC06
- IT group
- 02.99 Varia
- Active substances
- Berotralstatum
- Preparation type
- Originator product
- On the SL since
- 01/07/2022
- Last price change
- 01/07/2022
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Kaps 150 mg | 28 Stk | CHF 12'756.64 | CHF 13'396.10 | 01/07/2022 | B | 7680684640018 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
ORLADEYO wird vergütet als Monotherapie bei Patienten ab einem Alter von 12 Jahren zur routinemässigen Prävention wiederkehrender Attacken des hereditären Angioödems (HAE).
Die Einleitung und Überwachung der Behandlung erfolgt ausschliesslich über eines der folgenden Zentren: Universitätsspital Zürich, Inselspital Bern, Universitätsspital Basel, CHUV, HUG, Kantonsspital Luzern, Kantonsspital Aarau und Kantonsspital St. Gallen.
FAQ
Is Orladeyo covered by Swiss health insurance?
Yes, but only under conditions. Orladeyo is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Orladeyo cost in Switzerland?
The public price is the maximum price set by the FOPH and for Orladeyo ranges from CHF 13'396.10 to CHF 13'396.10 per pack. The ex-factory price ranges from CHF 12'756.64 to CHF 12'756.64. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages